XML 37 R30.htm IDEA: XBRL DOCUMENT v3.25.2
Restatement of Previously Issued Financial Statements (Tables)
6 Months Ended
Jun. 30, 2025
Accounting Changes and Error Corrections [Abstract]  
Schedule of Impact of Correction Misstatements

The impact of the correction of the misstatements is summarized below (in thousands):

 

 

As of
June 30, 2024

 

 

 

As Previously Reported

 

 

Restatement Impacts

 

 

As Restated

 

 

 

 

 

 

 

 

 

 

 

LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Convertible preferred stock, 5,000,000 shares authorized at June 30, 2024 and December 31, 2023:

 

 

 

 

 

 

 

 

 

Series X1 non-voting convertible preferred stock, $0.001 par value, 515,000 shares designated; 110,086 shares issued and outstanding at June 30, 2024 and December 31, 2023

 

$

 

 

$

53,543

 

 

$

53,543

 

Series X non-voting convertible preferred stock, $0.001 par value, 10,000 shares designated; 4,422 shares issued and outstanding at June 30, 2024 and December 31, 2023

 

 

 

 

 

2,151

 

 

 

2,151

 

 

 

 

 

 

 

 

 

 

 

Stockholders’ equity (deficit):

 

 

 

 

 

 

 

 

 

Convertible preferred stock, 5,000,000 shares authorized at June 30, 2024 and December 31, 2023:

 

 

 

 

 

 

 

 

 

Series X1 non-voting convertible preferred stock, $0.001 par value, 515,000 shares designated; 110,086 shares issued and outstanding at June 30, 2024 and December 31, 2023

 

 

 

 

 

 

 

 

 

Series X non-voting convertible preferred stock, $0.001 par value, 10,000 shares designated; 4,422 shares issued and outstanding at June 30, 2024 and December 31, 2023

 

 

 

 

 

 

 

 

 

Additional paid-in capital

 

 

379,400

 

 

 

(55,694

)

 

 

323,706

 

Total stockholders’ equity (deficit)

 

$

(8,501

)

 

$

(55,694

)

 

$

(64,195

)

 

 

 

For the Three Months
Ended June 30, 2024

 

 

For the Six Months
Ended June 30, 2024

 

 

 

As Previously Reported

 

 

As Restated

 

 

As Previously Reported

 

 

As Restated

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted earnings per share of common stock

 

$

(1.06

)

 

$

(0.92

)

 

$

(1.90

)

 

$

(1.61

)

Basic and diluted earnings per share of Series X and Series X1 non-voting convertible preferred stock

 

$

 

 

$

(51.29

)

 

$

 

 

$

(89.60

)

Weighted-average shares outstanding of Series X and Series X1 non-voting convertible preferred stock, basic and diluted

 

 

 

 

 

114,508

 

 

 

 

 

 

114,508